Usona in the News
Pioneering psychiatrist Dr. Charles L. Raison explores consciousness and psychedelics in mental health research
Dr. Charles L. Raison discusses his research on psychedelics and mental health, exploring how conscious experience impacts healing.
September 6, 2024 | Read More
Psilocybin for Depression: An Interview with Dr. Charles Raison
Dr. Charles Raison discusses psilocybin's potential in treating depression on the MPR Weekly Dose Podcast.
May 7, 2024 | MPR Weekly Dose Podcast
Charles L. Raison: Elucidating the role of conscious experience in the therapeutic effects of psychedelics as a means to optimize clinical outcomes
Dr. Charles Raison talks with Genomic Press about his path from science enthusiast to leading psychedelic therapy researcher and its impacts.
March 14, 2024 | Genomic Press
Chasing Life with Dr. Sanjay Gupta: Treating the Depressed Brain featuring Dr. Charles Raison (Podcast)
As the use of antidepressants have steadily risen since their introduction in the 1980s, what have we learned about depression?
November 14, 2023 | CNN
What Does Good Psychedelic Therapy Look Like?
As MDMA and psilocybin treatments become more mainstream, the therapy component has come under scrutiny. Here’s what’s common in many sessions...
June 3, 2023 | New York Times
When nothing else works
Could psychoactive substances like psilocybin, MDMA and ketamine finally crack the code on treatment-resistant depression, anxiety or PTSD?
May 2, 2023 | Madison Magazine
Kathleen Gallagher: How a Madison area non-profit is accelerating demand for psychedelic mushrooms used to treat mental illness
A look at the landscape of psychedelics being used to treat mental health and how Usona Institute to rising to meet the challenge.
August 9, 2022 | Milwaukee Journal Sentinel
Are you ready for the psychedelic revolution?
The psychedelic revolution in mental health treatment is on the way, with FDA approval likely in just a few years.
July 2, 2022 | NPR: To The Best of Our KnowledgeUpdates
Usona Statement on Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD) (uAspire)
March 20, 2024
Usona Institute Research Unveils New Compounds with Observed Psychedelic-like Activity
January 10, 2024
Usona statement on JAMA publication of PSIL201 data
August 31, 2023
Media Inquiries
MEDIA REQUESTMedia Inquiries
Please contact karen.burkhartzmeyer@usonainstitute.org with the following information:
- Name and organization
- Description of what you would like to cover
- Deadline